LYUDMYLA SINYENKO: Open Payments
NPI 1063751279 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $277 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $141 |
| SANOFI PASTEUR INC. | 4 | $114 |
| Lundbeck LLC | 4 | $84 |
| Lilly USA, LLC | 4 | $71 |
| Exact Sciences Corporation | 2 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Ozempic, REXULTI, MOUNJARO, The Cologuard Plus Collection Kit, Wegovy, Veozah, INGREZZA.
Industry payments across NM — which companies pay providers there.
